RAP 8.33% 19.5¢ resapp health limited

Ann: ResApp Submits De Novo Application to the FDA, page-3

  1. 2,148 Posts.
    lightbulb Created with Sketch. 39
    WOW! Great news .I think the most powerful bi..
    “This submission represents the culmination of years of development work and marks asignificant milestone towards commercialisation,” said Tony Keating, CEO and Managing Director.“These respiratory diseases are the most common illnesses seen in healthcare, and once clearedby the FDA ResAppDx-US will deliver substantial clinical benefits by providing actionableinformation to clinicians sooner. We are now entering a new and exciting phase in ResApp’sevolution as we prepare for the commercial launch of ResAppDx-US.”
    Hope this catches some attention today!
watchlist Created with Sketch. Add RAP (ASX) to my watchlist
(20min delay)
Mkt cap ! $153.4M
Open High Low Value Volume
18.5¢ 20.0¢ 18.5¢ $556.0K 2.913M

Buyers (Bids)

No. Vol. Price($)
8 263000 18.5¢

Sellers (Offers)

Price($) Vol. No.
19.5¢ 100958 2
View Market Depth
Last update - 16.10pm 17/06/2019 (20 minute delay) ?
0.015 ( 8.33 %)
Open High Low Volume
18.5¢ 20.0¢ 18.5¢ 1424545
Last updated 15.59pm 17/06/2019 (live) ?
RAP (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.